Failure of antioxidants to protect against angiotensin II-induced aortic rupture in aged apolipoprotein(E)-deficient mice

British Journal of Pharmacology

Volumn 152, Issue 6, 2007, Pages 880-890

  Jiang, F ^a   Jones, G T ^b   Dusting, G J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Abdominal aortic aneurysm; Aged; Angiotensin II; Antioxidants; Aortic rupture; Apolipoprotein E deficient; Metalloproteinase

Indexed keywords

ALPHA TOCOPHEROL; ANGIOTENSIN II; ANTIOXIDANT; APOLIPOPROTEIN E; ASCORBIC ACID; GELATINASE B; LOSARTAN; MALONALDEHYDE; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL AORTA ANEURYSM; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA RUPTURE; ARTERY DILATATION; ARTICLE; ATHEROSCLEROTIC PLAQUE; CELL STRAIN U937; CONTROLLED STUDY; FALSE ANEURYSM; HEMATOMA; IMMUNOHISTOCHEMISTRY; KIDNEY DYSFUNCTION; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYSTOLIC BLOOD PRESSURE; TREATMENT FAILURE;

AGING; ANGIOTENSIN II; ANIMALS; ANTIOXIDANTS; AORTIC RUPTURE; APOLIPOPROTEINS E; BLOOD PRESSURE; BLOTTING, WESTERN; CREATININE; HEME OXYGENASE-1; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY FUNCTION TESTS; MALE; MATRIX METALLOPROTEINASE 9; MICE; MICE, KNOCKOUT; OXIDATIVE STRESS; PROTEINURIA; THIOBARBITURIC ACID REACTIVE SUBSTANCES; U937 CELLS;

EID: 36049041629     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0707449     Document Type: Article

References (51)

1. Agarwal R, Campbell RC, Warnock DG (2004). Oxidative stress in hypertension and chronic kidney disease: role of angiotensin II. Semin Nephrol 24: 101-114.
2. Aizawa T, Ishizaka N, Taguchi J, Nagai R, Mori I, Tang SS et al. (2000). Heme oxygenase-1 is upregulated in the kidney of angiotensin II-induced hypertensive rats: possible role in renoprotection. Hypertension 35: 800-806.
3. Araujo M, Welch WJ (2006). Oxidative stress and nitric oxide in kidney function. Curr Opin Nephrol Hypertens 15: 72-77.
4. Arenas IA, Xu Y, Lopez-Jaramillo P, Davidge ST (2004). Angiotensin II-induced MMP-2 release from endothelial cells is mediated by TNF-alpha. Am J Physiol Cell Physiol 286: C779-C784.
5. Bellosta S, Via D, Canavesi M, Pfister P, Fumagalli R, Paoletti R et al. (1998). HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages. Arterioscler Thromb Vasc Biol 18: 1671-1678.
6. Bhaskaran M, Reddy K, Radhakrishanan N, Franki N, Ding G, Singhal PC (2003). Angiotensin II induces apoptosis in renal proximal tubular cells. Am J Physiol Renal Physiol 284: F955-F965.
7. Brewster UC, Perazella MA (2004). The renin-angiotensin-aldosterone system and the kidney: effects on kidney disease. Am J Med 116: 263-272.
8. Browatzki M, Larsen D, Pfeiffer CA, Gehrke SG, Schmidt J, Kranzhofer A et al. (2005). Angiotensin II stimulates matrix metalloproteinase secretion in human vascular smooth muscle cells via nuclear factor-kappaB and activator protein 1 in a redox-sensitive manner. J Vasc Res 42: 415-423.
9. Caron E, Liautard JP, Kohler S (1994). Differentiated U937 cells exhibit increased bactericidal activity upon LPS activation and discriminate between virulent and avirulent Listeria and Brucella species. J Leukoc Biol 56: 174-181.
10. Daugherty A, Manning MW, Cassis LA (2000). Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest 105: 1605-1612.
11. Gavrila D, Li WG, McCormick ML, Thomas M, Daugherty A, Cassis LA et al. (2005). Vitamin E inhibits abdominal aortic aneurysm formation in angiotensin II-infused apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 25: 1671-1677.
12. Guron GS, Grimberg ES, Basu S, Herlitz H (2006). Acute effects of the superoxide dismutase mimetic tempol on split kidney function in two-kidney one-clip hypertensive rats. J Hypertens 24: 387-394.
13. Hahn AW, Jonas U, Buhler FR, Resink TJ (1994). Activation of human peripheral monocytes by angiotensin II. FEBS Lett 347: 178-180.
14. Hanna IR, Taniyama Y, Szocs K, Rocic P, Griendling KK (2002). NAD(P)H oxidase-derived reactive oxygen species as mediators of angiotensin II signaling. Antioxid Redox Signal 4: 899-914.
15. Haugen EN, Croatt AJ, Nath KA (2000). Angiotensin II induces renal oxidant stress in vivo and heme oxygenase-1 in vivo and in vitro. Kidney Int 58: 144-152.
16. Jiang F, Jones GT, Husband AJ, Dusting GJ (2003). Cardiovascular protective effects of synthetic isoflavone derivatives in apolipoprotein E-deficient mice. J Vasc Res 40: 276-284.
17. Jiang F, Roberts SJ, Datla S, Dusting GJ (2006). NO modulates NADPH oxidase function via heme oxygenase-1 in human endothelial cells. Hypertension 48: 950-957.
18. Jones GT, Jiang F, McCormick SP, Dusting GJ (2005). Elastic lamina defects are an early feature of aortic lesions in the apolipoprotein E knockout mouse. J Vasc Res 42: 237-246.
19. Lopez-Boado YS, Wilson CL, Hooper LV, Gordon JI, Hultgren SJ, Parks WC (2000). Bacterial exposure induces and activates matrilysin in mucosal epithelial cells. J Cell Biol 148: 1305-1315.
20. Manning MW, Cassis LA, Daugherty A (2003). Differential effects of doxycycline, a broad-spectrum matrix metalloproteinase inhibitor, on angiotensin II-induced atherosclerosis and abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 23: 483-488.
21. Martin-McNulty B, Tham DM, da Cunha V, Ho JJ, Wilson DW, Rutledge JC et al. (2003). 17 beta-estradiol attenuates development of angiotensin II-induced aortic abdominal aneurysm in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 23: 1627-1632.
22. May JM, Qu ZC, Mendiratta S (1998). Protection and recycling of alpha-tocopherol in human erythrocytes by intracellular ascorbic acid. Arch Biochem Biophys 349: 281-289.
23. Mehta JL, Li DY, Yang H, Raizada MK (2002). Angiotensin II and IV stimulate expression and release of plasminogen activator inhibitor-1 in cultured human coronary artery endothelial cells. J Cardiovasc Pharmacol 39: 789-794.
24. Miller Jr FJ, Sharp WJ, Fang X, Oberley LW, Oberley TD, Weintraub NL (2002). Oxidative stress in human abdominal aortic aneurysms: a potential mediator of aneurysmal remodeling. Arterioscler Thromb Vasc Biol 22: 560-565.
25. Morin I, Li WQ, Su S, Ahmad M, Zafarullah M (1999). Induction of stromelysin gene expression by tumor necrosis factor alpha is inhibited by dexamethasone, salicylate, and N-acetylcysteine in synovial fibroblasts. J Pharmacol Exp Ther 289: 1634-1640.
26. Nakagami H, Takemoto M, Liao JK (2003). NADPH oxidase-derived superoxide anion mediates angiotensin II-induced cardiac hypertrophy. J Mol Cell Cardiol 35: 851-859.
27. Nakahashi TK, Hoshina K, Tsao PS, Sho E, Sho M, Karwowski JK et al. (2002). Flow loading induces macrophage antioxidative gene expression in experimental aneurysms. Arterioscler Thromb Vasc Biol 22: 2017-2022.
28. Nakamura K, Fushimi K, Kouchi H, Mihara K, Miyazaki M, Ohe T et al. (1998). Inhibitory effects of antioxidants on neonatal rat cardiac myocyte hypertrophy induced by tumor necrosis factor-alpha and angiotensin II. Circulation 98: 794-799.
29. Offord EA, Gautier JC, Avanti O, Scaletta C, Runge F, Kramer K et al. (2002). Photoprotective potential of lycopene, beta-carotene, vitamin E, vitamin C and carnosic acid in UVA-irradiated human skin fibroblasts. Free Radic Biol Med 32: 1293-1303.
30. Park JK, Muller DN, Mervaala EM, Dechend R, Fiebeler A, Schmidt F et al. (2000). Cerivastatin prevents angiotensin II-induced renal injury independent of blood pressure- and cholesterol-lowering effects. Kidney Int 58: 1420-1430.
31. Pradhan A, Umezu M, Fukagawa M (2006). Heme-oxygenase upregulation ameliorates angiotensin II-induced tubulointerstitial injury and salt-sensitive hypertension. Am J Nephrol 26: 552-561.
32. Prisant LM, Mondy III JS (2004). Abdominal aortic aneurysm. J Clin Hypertens (Greenwich) 6: 85-89.
33. Pueyo ME, Gonzalez W, Nicoletti A, Savoie F, Arnal JF, Michel JB (2000). Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-kappaB activation induced by intracellular oxidative stress. Arterioscler Thromb Vasc Biol 20: 645-651.
34. Quan S, Yang L, Shnouda S, Schwartzman ML, Nasjletti A, Goodman AI et al. (2004). Expression of human heme oxygenase-1 in the thick ascending limb attenuates angiotensin II-mediated increase in oxidative injury. Kidney Int 65: 1628-1639.
35. Rahat MA, Marom B, Bitterman H, Weiss-Cerem L, Kinarty A, Lahat N (2006). Hypoxia reduces the output of matrix metalloproteinase-9 (MMP-9) in monocytes by inhibiting its secretion and elevating membranal association. J Leukoc Biol 79: 706-718.
36. Remuzzi G, Perico N, Macia M, Ruggenenti P (2005). The role of renin-angiotensin-aldosterone system in the progression of chronic kidney disease. Kidney Int Suppl S57-S65.
37. Rodriguez-Iturbe B, Zhan CD, Quiroz Y, Sindhu RK, Vaziri ND (2003). Antioxidant-rich diet relieves hypertension and reduces renal immune infiltration in spontaneously hypertensive rats. Hypertension 41: 341-346.
38. Saraff K, Babamusta F, Cassis LA, Daugherty A (2003). Aortic dissection precedes formation of aneurysms and atherosclerosis in angiotensin II-infused, apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 23: 1621-1626.
39. Satoh K (1978). Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clin Chim Acta 90: 37-43.
40. Schupp M, Lee LD, Frost N, Umbreen S, Schmidt B, Unger T et al. (2006). Regulation of peroxisome proliferator-activated receptor gamma activity by losartan metabolites. Hypertension 47: 586-589.
41. Singh K, Bonaa KH, Jacobsen BK, Bjork L, Solberg S (2001). Prevalence of and risk factors for abdominal aortic aneurysms in a population-based study: the Tromso study. Am J Epidemiol 154: 236-244.
42. Slot C (1965). Plasma creatinine determination. A new and specific Jaffe reaction method. Scand J Clin Lab Invest 17: 381-387.
43. Stulak JM, Lerman A, Porcel MR, Caccitolo JA, Romero JC, Schaff HV et al. (2001). Renal vascular function in hypercholesterolemia is preserved by chronic antioxidant supplementation. J Am Soc Nephrol 12: 1882-1891.
44. Tanifuji C, Suzuki Y, Geot WM, Horikoshi S, Sugaya T, Ruiz-Ortega M et al. (2005). Reactive oxygen species-mediated signaling pathways in angiotensin II-induced MCP-1 expression of proximal tubular cells. Antioxid Redox Signal 7: 1261-1268.
45. Thomas M, Gavrila D, McCormick ML, Miller Jr FJ, Daugherty A, Cassis LA et al. (2006). Deletion of p47phox attenuates angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-deficient mice. Circulation 114: 404-413.
46. Varma R, Garrick R, McClung J, Frishman WH (2005). Chronic renal dysfunction as an independent risk factor for the development of cardiovascular disease. Cardiol Rev 13: 98-107.
47. Vaziri ND (2004). Roles of oxidative stress and antioxidant therapy in chronic kidney disease and hypertension. Curr Opin Nephrol Hypertens 13: 93-99.
48. Vera T, Kelsen S, Yanes LL, Reckelhoff JF, Stec DE (2007). Ho-1 induction lowers blood pressure and superoxide production in the renal medulla of Angiotensin Ii hypertensive mice. Am J Physiol Regul Integr Comp Physiol 292: R1472-R1478.
49. Wen M, Segerer S, Dantas M, Brown PA, Hudkins KL, Goodpaster T et al. (2002). Renal injury in apolipoprotein E-deficient mice. Lab Invest 82: 999-1006.
50. Wesseling S, Ishola Jr DA, Joles JA, Bluyssen HA, Koomans HA, Braam B (2005). Resistance to oxidative stress by chronic infusion of angiotensin II in mouse kidney is not mediated by the AT2 receptor. Am J Physiol Renal Physiol 288: F1191-F1200.
51. Zhang L, Ma Y, Zhang J, Cheng J, Du J (2005). A new cellular signaling mechanism for angiotensin II activation of NF-kappaB: an IkappaB-independent, RSK-mediated phosphorylation of p65. Arterioscler Thromb Vasc Biol 25: 1148-1153.